Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators

Figure 4

CCL20 expression. (a) CCL20 concentrations in pg/mL in the serum of control subjects and NASH patients. CCL20 was measured by ELISA as described in Section 2. Data represent mean ± SEM in triplicate (ELISA) from 39 different donors/sera of NASH patients. The levels of CCL20 were significantly increased in NASH patients and NASH patients with fibrosis compared with control subjects, with and , respectively. (b) On the mRNA level, CCL20 mRNA is not significantly increased in NASH patients with ().

(a)

(b)